N(1)Gly-DL-Asn-DL-Trp-DL-His-Gly-DL-Gly(Ac)-DL-Ala-DL-Pro-DL-Asp(1)-DL-Trp-DL-Phe-DL-Phe-DL-Asn-DL-Tyr-DL-Tyr-DL-Trp-OH
| Internal ID | 03b8838a-d4f3-48aa-9973-09dc608db798 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[2-[[2-[[2-[[6-acetyl-18-(2-amino-2-oxoethyl)-12-(1H-imidazol-5-ylmethyl)-15-(1H-indol-3-ylmethyl)-3-methyl-2,5,8,11,14,17,20,23,27-nonaoxo-1,4,7,10,13,16,19,22,26-nonazabicyclo[26.3.0]hentriacontane-25-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-amino-4-oxobutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid |
| SMILES (Canonical) | CC1C(=O)N2CCCC2C(=O)NC(CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)C(=O)C)CC3=CN=CN3)CC4=CNC5=CC=CC=C54)CC(=O)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CC9=CC=CC=C9)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O |
| SMILES (Isomeric) | CC1C(=O)N2CCCC2C(=O)NC(CC(=O)NCC(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCC(=O)NC(C(=O)N1)C(=O)C)CC3=CN=CN3)CC4=CNC5=CC=CC=C54)CC(=O)N)C(=O)NC(CC6=CNC7=CC=CC=C76)C(=O)NC(CC8=CC=CC=C8)C(=O)NC(CC9=CC=CC=C9)C(=O)NC(CC(=O)N)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)O |
| InChI | InChI=1S/C103H113N23O23/c1-54-102(147)126-35-15-26-83(126)100(145)123-81(46-86(132)110-51-87(133)114-79(44-84(104)130)97(142)119-77(41-61-48-108-70-24-13-10-21-67(61)70)96(141)121-78(43-63-50-106-53-112-63)90(135)111-52-88(134)125-89(55(2)127)101(146)113-54)99(144)120-76(40-60-47-107-69-23-12-9-20-66(60)69)95(140)117-72(36-56-16-5-3-6-17-56)91(136)115-73(37-57-18-7-4-8-19-57)93(138)122-80(45-85(105)131)98(143)118-74(38-58-27-31-64(128)32-28-58)92(137)116-75(39-59-29-33-65(129)34-30-59)94(139)124-82(103(148)149)42-62-49-109-71-25-14-11-22-68(62)71/h3-14,16-25,27-34,47-50,53-54,72-83,89,107-109,128-129H,15,26,35-46,51-52H2,1-2H3,(H2,104,130)(H2,105,131)(H,106,112)(H,110,132)(H,111,135)(H,113,146)(H,114,133)(H,115,136)(H,116,137)(H,117,140)(H,118,143)(H,119,142)(H,120,144)(H,121,141)(H,122,138)(H,123,145)(H,124,139)(H,125,134)(H,148,149) |
| InChI Key | QEHKVSXORDXCMU-UHFFFAOYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C103H113N23O23 |
| Molecular Weight | 2041.10 g/mol |
| Exact Mass | 2040.84132178 g/mol |
| Topological Polar Surface Area (TPSA) | 714.00 Ų |
| XlogP | 1.70 |
| Atomic LogP (AlogP) | -2.12 |
| H-Bond Acceptor | 23 |
| H-Bond Donor | 24 |
| Rotatable Bonds | 36 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.7287 | 72.87% |
| Caco-2 | - | 0.8629 | 86.29% |
| Blood Brain Barrier | - | 0.9500 | 95.00% |
| Human oral bioavailability | - | 0.6857 | 68.57% |
| Subcellular localzation | Mitochondria | 0.5241 | 52.41% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8085 | 80.85% |
| OATP1B3 inhibitior | + | 0.9329 | 93.29% |
| MATE1 inhibitior | - | 0.9409 | 94.09% |
| OCT2 inhibitior | - | 0.8750 | 87.50% |
| BSEP inhibitior | + | 0.9696 | 96.96% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8818 | 88.18% |
| CYP3A4 substrate | + | 0.7583 | 75.83% |
| CYP2C9 substrate | - | 0.6120 | 61.20% |
| CYP2D6 substrate | - | 0.8608 | 86.08% |
| CYP3A4 inhibition | - | 0.7989 | 79.89% |
| CYP2C9 inhibition | - | 0.8660 | 86.60% |
| CYP2C19 inhibition | - | 0.8213 | 82.13% |
| CYP2D6 inhibition | - | 0.9094 | 90.94% |
| CYP1A2 inhibition | - | 0.8777 | 87.77% |
| CYP2C8 inhibition | + | 0.8494 | 84.94% |
| CYP inhibitory promiscuity | - | 0.6599 | 65.99% |
| UGT catelyzed | + | 0.6000 | 60.00% |
| Carcinogenicity (binary) | - | 0.9000 | 90.00% |
| Carcinogenicity (trinary) | Non-required | 0.5940 | 59.40% |
| Eye corrosion | - | 0.9915 | 99.15% |
| Eye irritation | - | 0.8953 | 89.53% |
| Skin irritation | - | 0.8060 | 80.60% |
| Skin corrosion | - | 0.9434 | 94.34% |
| Ames mutagenesis | - | 0.7900 | 79.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7167 | 71.67% |
| Micronuclear | + | 0.8400 | 84.00% |
| Hepatotoxicity | - | 0.5809 | 58.09% |
| skin sensitisation | - | 0.8998 | 89.98% |
| Respiratory toxicity | + | 0.9111 | 91.11% |
| Reproductive toxicity | + | 0.9778 | 97.78% |
| Mitochondrial toxicity | + | 0.9500 | 95.00% |
| Nephrotoxicity | + | 0.6299 | 62.99% |
| Acute Oral Toxicity (c) | III | 0.5859 | 58.59% |
| Estrogen receptor binding | - | 0.5836 | 58.36% |
| Androgen receptor binding | + | 0.7143 | 71.43% |
| Thyroid receptor binding | + | 0.8260 | 82.60% |
| Glucocorticoid receptor binding | + | 0.8527 | 85.27% |
| Aromatase binding | + | 0.8274 | 82.74% |
| PPAR gamma | + | 0.7725 | 77.25% |
| Honey bee toxicity | - | 0.6363 | 63.63% |
| Biodegradation | - | 0.8500 | 85.00% |
| Crustacea aquatic toxicity | - | 0.6449 | 64.49% |
| Fish aquatic toxicity | - | 0.3846 | 38.46% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.93% | 98.95% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.66% | 97.64% |
| CHEMBL1951 | P21397 | Monoamine oxidase A | 99.46% | 91.49% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 99.37% | 96.09% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 99.00% | 90.20% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 98.98% | 83.82% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.72% | 91.11% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 98.68% | 85.14% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 98.26% | 88.56% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.01% | 90.08% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 95.80% | 95.89% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 95.01% | 91.81% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 94.73% | 95.56% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 94.68% | 94.45% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 93.66% | 96.31% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 92.68% | 88.42% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 92.23% | 97.23% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.11% | 95.38% |
| CHEMBL2535 | P11166 | Glucose transporter | 92.10% | 98.75% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 91.94% | 98.59% |
| CHEMBL2093869 | P05106 | Integrin alpha-IIb/beta-3 | 91.46% | 95.42% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 91.32% | 99.23% |
| CHEMBL1860 | P10827 | Thyroid hormone receptor alpha | 90.85% | 99.15% |
| CHEMBL3202 | P48147 | Prolyl endopeptidase | 90.64% | 90.65% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 90.59% | 98.24% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 89.84% | 99.52% |
| CHEMBL3091268 | Q92753 | Nuclear receptor ROR-beta | 89.19% | 95.50% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 89.18% | 92.29% |
| CHEMBL5805 | Q9NR97 | Toll-like receptor 8 | 88.58% | 96.25% |
| CHEMBL3837 | P07711 | Cathepsin L | 88.50% | 96.61% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 88.32% | 96.90% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.40% | 93.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 87.03% | 97.14% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 86.65% | 82.38% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 86.63% | 83.10% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.39% | 89.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 85.77% | 97.09% |
| CHEMBL5896 | O75164 | Lysine-specific demethylase 4A | 85.72% | 99.09% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 85.55% | 96.11% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 85.49% | 99.17% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 85.20% | 92.97% |
| CHEMBL264 | Q9Y5N1 | Histamine H3 receptor | 85.19% | 91.43% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 84.39% | 94.66% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 84.32% | 98.33% |
| CHEMBL2821 | P00748 | Coagulation factor XII | 83.66% | 96.21% |
| CHEMBL3713062 | P10646 | Tissue factor pathway inhibitor | 83.37% | 97.33% |
| CHEMBL2095226 | P05556 | Integrin alpha-5/beta-1 | 83.20% | 96.39% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 82.93% | 97.43% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 82.78% | 93.03% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 82.61% | 100.00% |
| CHEMBL1921 | P47901 | Vasopressin V1b receptor | 82.43% | 92.50% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 81.52% | 92.12% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 81.48% | 99.18% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 81.44% | 100.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.23% | 95.50% |
| CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 81.15% | 86.33% |
| CHEMBL2096618 | P11274 | Bcr/Abl fusion protein | 81.02% | 85.83% |
| CHEMBL1795185 | Q58F21 | Bromodomain testis-specific protein | 80.42% | 89.76% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 80.31% | 96.67% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 80.08% | 95.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 163061914 |
| LOTUS | LTS0272443 |
| wikiData | Q104195733 |